Delivery Order SPE2DB22D2206-SPE2DB25FJC31
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. This non-set-aside, firm fixed-price delivery order carries a ceiling value of $1,045.92 and is scheduled for ultimate completion by May 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) with a ceiling value of $2,072.32. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit quantities. This is a firm fixed-price delivery order valued at $1,344.96, with an ultimate completion date of September 22, 2025. The award is not set-aside and represents a competitive procurement of pharmaceutical products for federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The $2,181.63 contract has an ultimate completion date of December 5, 2022 and is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceuticals and medical supplies to support military...
- The Defense Logistics Agency awarded a delivery order valued at $1,307.00 to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (60 single-use containers) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger prime contract vehicle. The pharmaceutical will be delivered to the company's distribution facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30 count) with a ceiling value of $1,381.69. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award was not...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,834.62 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $23,086.01 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Cyclosporine 0.05% eye emulsion in 60-unit quantities. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's...
- This delivery order, valued at $1,125.66, was awarded to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Cyclosporine 0.05% eye emulsion (60-unit quantity). The award was made by the Defense Logistics Agency, a Department of Defense entity responsible for managing the military supply chain. The contract employs firm fixed-price pricing and is classified as a non-set-aside award, indicating it was competitively procured. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,872.12 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Cyclosporine 0.05% Eye Emulsion (30 units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by August 7, 2025, reflecting the expedited nature of pharmaceutical supply fulfillment to support federal...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJC31Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $6,435.48 and a firm fixed price structure. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement requirements. Performance will be fulfilled from the company's Conshohocken, Pennsylvania location, the corporate headquarters of this major pharmaceutical distributor and critical vendor for federal medical procurement needs. AmerisourceBergen Drug Corp's DLA IDC enables the supply of a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The company maintains an extensive portfolio of federal medical contract awards for various therapeutic domains, including specialty medications, vaccines, and medical devices. The July 2025 delivery order for Cyclosporine represents a routine fulfillment under this larger procurement vehicle, supporting the ongoing pharmaceutical supply requirements of military and federal healthcare operations through the established prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 7/28/25 |